SHAUN MILBY: Open Payments
NPI 1043686371 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,523 in 95 payments from 21 companies in 2025. Trend: 2023 $1,638 · 2024 $1,859 · 2025 $1,523
Food & beverage: $1,523
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $297 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $249 |
| Novo Nordisk Inc | 19 | $219 |
| Phathom Pharmaceuticals, Inc. | 4 | $83 |
| Lilly USA, LLC | 4 | $77 |
| PFIZER INC. | 4 | $74 |
| GlaxoSmithKline, LLC. | 4 | $66 |
| Exact Sciences Corporation | 4 | $61 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Corcept Therapeutics | 3 | $58 |
Products named: CAPLYTA, Wegovy, VRAYLAR, QULIPTA, UBRELVY, VOQUEZNA, NURTEC ODT, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
